Use of an antiviral mouthwash as a barrier measure in the SARS-CoV-2 transmission in adults with asymptomatic to mild COVID-19: a multicentre, randomized, double-blind controlled trial

OBJECTIVES: To determine if commercially available mouthwash with β-cyclodextrin and citrox (bioflavonoids) (CDCM) could decrease the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) salivary viral load. METHODS: In this randomized controlled trial, severe acute respiratory syndrome coro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Microbiol Infect
Auteurs principaux: Carrouel, Florence, Valette, Martine, Gadea, Emilie, Esparcieux, Aurélie, Illes, Gabriela, Langlois, Marie Elodie, Perrier, Hervé, Dussart, Claude, Tramini, Paul, Ribaud, Mélina, Bouscambert-Duchamp, Maude, Bourgeois, Denis
Format: Artigo
Langue:Inglês
Publié: The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases. 2021
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8142805/
https://ncbi.nlm.nih.gov/pubmed/34044151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cmi.2021.05.028
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires